Company Description
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally.
The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.
The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications.
This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services.
The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter, as well as sells disposable parts for lithotripters and electrodes.
The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services.
It markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents.
The company serves hospitals, urology clinics, and research institutions. EDAP TMS S.A. was incorporated in 1979 and is based in Lyon, France.
| Country | France |
| Founded | 1979 |
| IPO Date | Jul 31, 1997 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 307 |
| CEO | Ryan Rhodes |
Contact Details
Address: Parc D'activites La Poudrette Lamartine, 4 Rue Du Dauphine 69120 Vaulx En Velin, I0 France | |
| Website | edap-tms.com |
Stock Details
| Ticker Symbol | EDAP |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001041934 |
| CUSIP Number | 268311107 |
| ISIN Number | US2683111072 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Marc Oczachowski | Executive Chairman |
| Ryan Rhodes | Chief Executive Officer and Director |
| Ken Mobeck | Chief Financial Officer |
| Carre Emmanuel | Chief Operating Officer |
| Francois Dietsch | Chief Accounting Officer |
| Blandine Confort | Head of Legal Affairs and Investor Relations and Secretary |
| Frederic Pech | President of EDAP TMS France |
| Jean-Francois Bachelard | President and Chief Executive Officer of Edaptechnomed Co. Ltd. |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 16, 2024 | EFFECT | Notice of Effectiveness |
| Apr 5, 2024 | F-3 | Filing |
| Mar 28, 2024 | 20-F | Annual and transition report of foreign private issuers |
| Mar 27, 2024 | 6-K | Report of foreign issuer |
| Mar 4, 2024 | 6-K | Report of foreign issuer |
| Feb 2, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 2, 2024 | 6-K | Report of foreign issuer |
| Dec 7, 2023 | 6-K | Report of foreign issuer |
| Nov 9, 2023 | 6-K | Report of foreign issuer |
| Aug 24, 2023 | 6-K | Report of foreign issuer |